申请人:Threshold Pharmaceuticals, Inc.
公开号:EP2336141A2
公开(公告)日:2011-06-22
Phosphoramidate alkylator prodrugs can be used to treat cancer when administered alone or in combination with one or more other anti-neoplastic agents.
磷酰胺烷化剂原药可单独或与一种或多种其他抗肿瘤药物联合用于治疗癌症。